Clinical outcomes and peritoneal histology in patients starting peritoneal dialysis are related to diabetic status and serum albumin levels

Kidney International

Volumn 73, Issue SUPPL. 108, 2008, Pages

  Contreras Velazquez J C ^a   Soto, V ^b   Jaramillo Rodriguez Y ^a   Samaniego Rios L I ^a   Quiones Perez V ^a   Avila M ^b   Amato, D ^b   Paniagua, R ^b  

^a Hospital General de Zona IMSS   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

Diabetes; Inflammation; Mortality; Peritoneal dialysis; Peritoneal histology; Serum albumin

Indexed keywords

SERUM ALBUMIN;

ABDOMINAL SURGERY; ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MESOTHELIUM CELL; MICROSCOPY; MORTALITY; PERITONEAL BIOPSY; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SCLEROSIS; UREMIA; BIOPSY; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; PERITONEUM; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; BIOPSY; CASE-CONTROL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; PROSPECTIVE STUDIES; SCLEROSIS; SERUM ALBUMIN; TREATMENT OUTCOME; UREMIA;

EID: 44449123809     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002599     Document Type: Article

References (37)

1. Davies SJ, Phillips L, Griffiths AM et al. What really happens to people in long-term peritoneal dialysis? Kidney Int 1998; 54: 2207-2217.
2. Selgas R, Bajo MA, Del Peso G et al. Preserving the peritoneal dialysis membrane in long-term peritoneal dialysis patients. Semin Dial 1995; 8: 326-332.
3. Krediet RT, Lindholm B, Rippe B. Pathophysiology of peritoneal membrane failure. Perit Dial Int 2000; 20(Suppl 4): S22-S42.
4. Topley N. Membrane longevity in peritoneal dialysis: impact of infection and bio-incompatible solutions. Adv Ren Replace Ther 1998; 5: 179-184.
5. Topley N, Alobaidi Hm, Davies M et al. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988; 34: 404-411.
6. Williams JD, Craig KJ, Topley N et al. Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int 2003; 63(Suppl 84): S158-S161.
7. Williams JD, Craig KJ, Topley N et al. Peritoneal Biopsy Study Group. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-479.
8. Stoenoiu MS, De Vriese AS, Brouet A et al. Experimental diabetes induces functional and structural changes in the peritoneum. Kidney Int 2002; 62: 668-678.
9. van Esch S, Zweers MM, Jansen MA et al. Determinants of peritoneal solute transport rates in newly started non-diabetic peritoneal dialysis patients. Perit Dial Int 2004; 24: 554-561.
10. Bertoli SV, Buzzi L, Ciurlino D et al. Morpho-functional study of peritoneum in peritoneal dialysis patients. J Nephrol 2003; 16: 373-378.
11. Paniagua R, Amato D, Correa-Rotter R et al. Correlation between the peritoneal equilibration test and the dialysis adequacy and transport test for peritoneal transport type characterization. Perit Dial Int 2000; 20: 53-59.
12. Goncalves S, Pecoits-Filho R, Perreto S et al. Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrol Dial Transplant 2006; 21: 2788-2794.
13. Magnusson M, Magnusson KE, Sundqvist T et al. Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure. Gut 1991; 32: 754-759.
14. Zuckerman MJ, Buchwald D, Watts MT. Intestinal permeability to 51Cr-EDTA in patients on chronic ambulatory peritoneal dialysis. Nephron 1994; 68: 408-409.
15. el-Lakany S, Eagon PK, Gavaler JS et al. Gastrointestinal function, morphology, and immune status in uremia. Nutrition 1990; 6: 461-468.
16. Strid H, Simren M, Stotzer PO et al. Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth. Digestion 2003; 67: 129-137.
17. Sarno S, Erasmas LP, Haslbeck M et al. Orocaecal transit, bacterial overgrowth and hydrogen production in diabetes mellitus. Ital J Gastroenterol 1993; 25: 490-496.
18. Cuoco L, Montalto M, Jorizzo RA et al. Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics. Hepatogastroenterology 2002; 49: 1582-1586.
19. Yáñez-Mó, Lara-Pezzi E, Selgas R et al. Peritoneal dialysis induces an epithelial-mesenchymal transition of mesothelial cells. N Eng J Med 2003; 348: 403-413.
20. Aroeira LS, Aguilera A, Selgas R et al. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis 2005; 46: 938-948.
21. Offner FA, Feichtinger H, Stadlmann S et al. Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. Am J Pathol 1996; 148: 1679-1688.
22. Border WA, Noble NA. Transforming growth factor b in tissue fibrosis. N Engl J Med 1994; 331: 1286-1292.
23. Flessner MF, Choi J, Vanpelt H et al. Correlating structure with solute and water transport in a chronic model of peritoneal inflammation. Am J Physiol Renal Physiol 2006; 290: F232-F240.
24. Zareie M, De Vriese AS, Hekking LH et al. Immunopathological changes in a uraemic rat model for peritoneal dialysis. Nephrol Dial Transplant 2005; 20: 1350-1361.
25. Rodrigues AS, Almeida M, Fonseca I et al. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation. Nephrol Dial Transplant 2006; 21: 763-769.
26. Paniagua R, Frías Y, Ventura MJ et al. C-reactive protein and anti-Chlamydia pneumoniae antibodies as risk factors of cardiovascular death in incident patients on peritoneal dialysis. Perit Dial Int 2003; 23: 132-137.
27. Chung SH, Heimburger O, Stenvinkel P et al. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant 2003; 18: 590-597.
28. Qureshi AR, Alvestrand A, Divino-Filho JC et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002; 13(Suppl 1): S28-S36.
29. Johnson DW, Wiggins KJ, Armstrong KA et al. Elevated white cell count at commencement of peritoneal dialysis predicts overall and cardiac mortality. Kidney Int 2005; 67: 738-743.
30. Kazmi WH, Gilbertson DT, Obrador GT et al. Effect of comorbidity on the increased mortality associated with early initiation of dialysis. Am J Kidney Dis 2005; 46: 887-896.
31. Khan SS, Xue JL, Kazmi WH et al. Does predialysis nephrology care influence patient survival after initiation of dialysis? Kidney Int 2005; 67: 1038-1046.
32. Chen W, Guo LJ, Wang T. Extracellular water/intracellular water is a strong predictor of patient survival in incident peritoneal dialysis patients. Blood Purif 2007; 25: 260-266.
33. Jansen MA, Termorshuizen F, Korevaar JC et al. Predictors of survival in anuric peritoneal dialysis patients. Kidney Int 2005; 68: 1199-1205.
34. Paniagua R, Amato D, Vonesh E et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: 1307-1320.
35. Mallamaci F, Tripepi G, Cutrupi S et al. Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int 2005; 67: 2330-2337.
36. Leaños-Miranda A, Garduño-Espinoza J, Martínez- García MC et al. Factores asociados a la falla del catiter de diálisis peritoneal en insuficiencia renal crónica. Rev Invest Clin 1997; 49: 189-195.
37. Twardowski ZJ. The fast peritoneal equilibration test. Semin Dial 1990; 3: 141-142.